Mats Wahlstrom, Director at Coherus BioSciences, Inc. (CHRS), sold 236,132 shares at $20.09 ($4.8M) on 2020-03-03, disclosed to the SEC on 2020-03-05.
Open-market sale of $4.8M CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.09 | 113,844 | $2.3M | 48.1% |
| 2 | $20.09 | 113,844 | $2.3M | 48.1% |
| 3 | $20.89 | 4,222 | $88K | 1.9% |
| 4 | $20.89 | 4,222 | $88K | 1.9% |
| Total | $20.12 avg | 236,132 | $4.8M | 100% |
| Filing → |
| TLSI | BUY | 2024-11-25 | $23K | — | Filing → |
| TLSI | BUY | 2024-11-22 | $47K | — | Filing → |
| CHRS | SELL | 2020-06-19 | $6.9M | — | Filing → |